Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of CAD 519.14 billion. The enterprise value is 582.28 billion.
| Market Cap | 519.14B |
| Enterprise Value | 582.28B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Sep 15, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.77% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 81.34% |
| Float | 2.46B |
Valuation Ratios
The trailing PE ratio is 185.57 and the forward PE ratio is 17.38.
| PE Ratio | 185.57 |
| Forward PE | 17.38 |
| PS Ratio | 5.43 |
| PB Ratio | 8.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.80 |
| P/OCF Ratio | 19.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.66, with an EV/FCF ratio of 27.81.
| EV / Earnings | 167.21 |
| EV / Sales | 6.06 |
| EV / EBITDA | 13.66 |
| EV / EBIT | 17.25 |
| EV / FCF | 27.81 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 1.20.
| Current Ratio | 1.35 |
| Quick Ratio | 0.81 |
| Debt / Equity | 1.20 |
| Debt / EBITDA | 1.80 |
| Debt / FCF | 3.66 |
| Interest Coverage | 12.08 |
Financial Efficiency
Return on equity (ROE) is 5.06% and return on invested capital (ROIC) is 13.69%.
| Return on Equity (ROE) | 5.06% |
| Return on Assets (ROA) | 11.29% |
| Return on Invested Capital (ROIC) | 13.69% |
| Return on Capital Employed (ROCE) | 22.79% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.29M |
| Profits Per Employee | 47,059 |
| Employee Count | 75,000 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.65 |
Taxes
In the past 12 months, Merck & Co. has paid 3.28 billion in taxes.
| Income Tax | 3.28B |
| Effective Tax Rate | 48.57% |
Stock Price Statistics
The stock price has increased by +57.91% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +57.91% |
| 50-Day Moving Average | 32.49 |
| 200-Day Moving Average | 28.65 |
| Relative Strength Index (RSI) | 52.34 |
| Average Volume (20 Days) | 27,482 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.59 |
Income Statement
In the last 12 months, Merck & Co. had revenue of CAD 95.65 billion and earned 3.48 billion in profits. Earnings per share was 0.18.
| Revenue | 95.65B |
| Gross Profit | 71.93B |
| Operating Income | 33.63B |
| Pretax Income | 6.76B |
| Net Income | 3.48B |
| EBITDA | 41.87B |
| EBIT | 33.63B |
| Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has 13.70 billion in cash and 76.52 billion in debt, with a net cash position of -62.82 billion.
| Cash & Cash Equivalents | 13.70B |
| Total Debt | 76.52B |
| Net Cash | -62.82B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 63.81B |
| Book Value Per Share | 3.23 |
| Working Capital | 14.40B |
Cash Flow
In the last 12 months, operating cash flow was 26.55 billion and capital expenditures -5.62 billion, giving a free cash flow of 20.93 billion.
| Operating Cash Flow | 26.55B |
| Capital Expenditures | -5.62B |
| Depreciation & Amortization | 8.28B |
| Net Borrowing | 18.17B |
| Free Cash Flow | 20.93B |
| FCF Per Share | n/a |
Margins
Gross margin is 75.20%, with operating and profit margins of 35.16% and 3.64%.
| Gross Margin | 75.20% |
| Operating Margin | 35.16% |
| Pretax Margin | 7.07% |
| Profit Margin | 3.64% |
| EBITDA Margin | 43.77% |
| EBIT Margin | 35.16% |
| FCF Margin | 21.76% |
Dividends & Yields
This stock pays an annual dividend of 0.77, which amounts to a dividend yield of 2.35%.
| Dividend Per Share | 0.77 |
| Dividend Yield | 2.35% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 341.05% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.77% |
| Shareholder Yield | 4.11% |
| Earnings Yield | 0.54% |
| FCF Yield | 4.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Merck & Co. has an Altman Z-Score of 3.85 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.85 |
| Piotroski F-Score | 4 |